Home Menu

Site Navigation



Parkinson's Disease Tulip


advertisement
NeuroTalk Support Groups > > >

Georgetown Receives FDA Clearance for Trial with Nilotinib in Alzheim

Reply
Page 2 of 2 1 2
 
Thread Tools Display Modes
Old 10-07-2016, 08:46 PM #11
jeffreyn jeffreyn is offline
Member
  
Join Date: Apr 2016
Location: Australia
Posts: 352
8 yr Member
jeffreyn jeffreyn is offline
Member
 
Join Date: Apr 2016
Location: Australia
Posts: 352
8 yr Member
Default A reference to a new GU nilotinib trial for PD?
Alan Hoffman, one of the participants in the first GU nilotinib trial for PD, has just added a new post to his blog.

If I've understood him correctly, he says that the next trial is planned to begin in January. He also says that Novartis have promised in writing to provide Tasigna for all trial participants after the trial ends.

The Continuing Saga of an Adventurous Life with Parkinson's Disease
jeffreyn is offline   Reply With QuoteReply With Quote
"Thanks for this!" says:
lab rat (10-12-2016), RLSmi (10-16-2016), Tupelo3 (10-07-2016), zanpar321 (10-07-2016)

advertisement
Reply
Page 2 of 2 1 2

Tags
alzheimers, clearance, fda, parkinsons, receives

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Similar Threads
Thread Thread Starter Forum Replies Last Post
A third clincal trial site for Nilotinib receives FDA approval Tupelo3 Parkinson's Disease 0 09-14-2016 01:54 PM
Six month follow up on Nilotinib trial. Betsy859 Parkinson's Disease 30 07-17-2016 05:52 PM


All times are GMT -5. The time now is 08:27 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

All posts copyright their original authors.

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.

Always consult your doctor before trying anything you read here.

Home